Lava Therapeutics is a developer of a bispecific antibody platform used to engage gamma-delta T cells for the treatment of cancer.
Rankings by

National Ranking273rd
in The Netherlands Regional Ranking5788th
in Western Europe Global Ranking24807th
worldwide